Comments
Loading...
Cardiff Oncology (NASDAQ:CRDF) Stock, Earnings Estimates, EPS, And Revenue
Cardiff Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 27
EPS Estimate
$-0.260
Quarterly Revenue Estimate
$73.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$688.00K
Analyze the earnings history of Cardiff Oncology using advanced sorting and filters.
Data brought to you by Benzinga APIs
Cardiff Oncology (CRDF) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.25 | $-0.27 | 7.41 % |
| Q2 | 2024-08-08 | $-0.26 | $-0.25 | -4.00 % |
| Q1 | 2024-05-02 | $-0.22 | $-0.25 | 12.0 % |
| Q4 | 2024-02-29 | $-0.21 | $-0.28 | 25.0 % |
Cardiff Oncology (CRDF) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $165.00K | $80.00K | 106.3 % |
| Q2 | 2024-08-08 | $163.00K | $60.00K | 171.7 % |
| Q1 | 2024-05-02 | $205.00K | $50.00K | 310.0 % |
| Q4 | 2024-02-29 | $156.00K | $40.00K | 290.0 % |
FAQ
When is Cardiff Oncology (NASDAQ:CRDF) reporting earnings?
Cardiff Oncology (CRDF) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Cardiff Oncology (NASDAQ:CRDF)?
The Actual EPS was $-0.25, which beat the estimate of $-0.27.
What were Cardiff Oncology’s (NASDAQ:CRDF) revenues?
The Actual Revenue was $165K, which beat the estimate of $80K.
Browse earnings estimates, EPS, and revenue on all stocks.